Adjuvant therapy for rectal cancer cannot be based on the results of other surgeons
- 1 August 2002
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 89 (8) , 946-947
- https://doi.org/10.1046/j.1365-2168.2002.02139.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancerBritish Journal of Surgery, 2002
- Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practiceBritish Journal of Surgery, 2002
- Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trialsThe Lancet, 2001
- Impact of Surgical and Pathologic Variables in Rectal Cancer: A United States Community and Cooperative Group ReportJournal of Clinical Oncology, 2001
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Role of the surgeon as a variable in the treatment of rectal cancerSeminars in Surgical Oncology, 2000
- Effect of a surgical training programme on outcome of rectal cancer in the County of StockholmThe Lancet, 2000
- Adjuvant chemotherapy in colorectal carcinomaDiseases of the Colon & Rectum, 1997
- Mesorectal excision for rectal cancerThe Lancet, 1993
- Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum:Clinicopathologic correlation and implications for adjuvant therapyCancer, 1974